Current therapy of myelodysplastic syndromes

AM Zeidan, Y Linhares, SD Gore - Blood Reviews, 2013 - Elsevier
After being a neglected and poorly-understood disorder for many years, there has been a
recent explosion of data regarding the complex pathogenesis of myelodysplastic syndromes …

Unravelling the epigenome of myelodysplastic syndrome: Diagnosis, prognosis, and response to therapy

DR Bond, HJ Lee, AK Enjeti - Cancers, 2020 - mdpi.com
Simple Summary Myelodysplastic syndrome (MDS) is a type of blood cancer that mostly
affects older individuals. Invasive tests to obtain bone samples are used to diagnose MDS …

Sensitivity of hematological malignancies to graft-versus-host effects: an EBMT megafile analysis

M Stern, LC De Wreede, R Brand, A Van Biezen… - Leukemia, 2014 - nature.com
After allogeneic stem cell transplantation, graft-versus-host disease (GvHD) occurs through
recognition of histocompatibility mismatches by donor T lymphocytes. The same mechanism …

[HTML][HTML] Back to the future! The evolving role of maintenance therapy after hematopoietic stem cell transplantation

CS Hourigan, P McCarthy, M De Lima - Biology of Blood and Marrow …, 2014 - Elsevier
Relapse is a devastating event for patients with hematologic cancers treated with
hematopoietic stem cell transplantation. In most situations, relapse treatment options are …

Combination of azacitidine and lenalidomide in myelodysplastic syndromes or acute myeloid leukemia—a wise liaison?

U Platzbecker, U Germing - Leukemia, 2013 - nature.com
Abstract Treatment options for older patients with advanced myelodysplastic syndromes
(MDS) or acute myeloid leukemia (AML) are limited and the prognosis remains poor, thereby …

Myelodysplastic syndromes: toward a risk-adapted treatment approach

B Faltas, A Zeidan, U Gergis - Expert Review of Hematology, 2013 - Taylor & Francis
Several classification and scoring systems have been developed in myelodysplastic
syndromes (MDS to predict the risk of progression to acute myeloid leukemia and survival …

Treatment of Crohn's disease complicated with myelodysplastic syndrome via allogeneic hematopoietic stem cell transplantation: case report and literature review

C Hu, L Lv, D Liu, J Huo - Clinical Journal of Gastroenterology, 2014 - Springer
Crohn's disease (CD) is a chronic inflammatory disease of the gastrointestinal tract arising in
individuals with genetic predisposing factors and abnormalities of the immune system …

[HTML][HTML] Allogeneic hematopoietic stem cell transplantation for patients with acute leukemia

Y Chen, Y Xu, G Fu, Y Liu, J Peng, B Fu… - Chinese Journal of …, 2013 - ncbi.nlm.nih.gov
Objective The purposes of this study were to assess the efficacy of allogeneic hematopoietic
stem cell transplantation (HSCT) for acute leukemia (AL) and analyze the factors affecting …

Results of allogeneic stem cell transplantation in the Spanish MDS registry: prognostic factors for low risk patients

MD Campelo, M Sánchez-Barba, VGG de Soria… - Leukemia research, 2014 - Elsevier
Although new agents have been approved for the treatment of MDS, the only curative
approach is allogeneic hematopoietic stem cell transplantation (HSCT) and thus, in …

[HTML][HTML] Personalized medicine in myelodysplastic syndromes: wishful thinking or already clinical reality?

U Platzbecker, P Fenaux - Haematologica, 2015 - ncbi.nlm.nih.gov
The work of Fraser et al. represents an important step in our understanding of the complex
interplay between erythroid and macrophage biology in the regulation of red cell production …